Tissue polypeptide antigen (TPA) in pancreatic cancer diagnosis.
作者信息
Panucci A, Fabris C, Del Favero G, Basso D, Marchioro L, Piccoli A, Burlina A, Naccarato R
出版信息
Br J Cancer. 1985 Nov;52(5):801-3. doi: 10.1038/bjc.1985.262.
Abstract
摘要
相似文献
1
Tissue polypeptide antigen (TPA) in pancreatic cancer diagnosis.
Br J Cancer. 1985 Nov;52(5):801-3. doi: 10.1038/bjc.1985.262.
2
3
Is tissue polypeptide antigen more accurate than serum CEA for diagnosing pancreatic cancer?
J Clin Pathol. 1986 Jan;39(1):75-7. doi: 10.1136/jcp.39.1.75.
4
Tissue polypeptide antigen, galactosyltransferase isoenzyme II and pancreatic oncofetal antigen serum determination: role in pancreatic cancer diagnosis.
Int J Pancreatol. 1988;3 Suppl 1:S95-100.
5
[Biohumeral markers in the diagnosis of pancreatic carcinoma].
Recenti Prog Med. 1985 Jul-Aug;76(7-8):385-91.
6
[CEA, TPA and APP as a guide in the surgical therapy and follow-up of pancreatic cancer].
Minerva Med. 1986 Mar 31;77(13):489-93.
7
[The role of CEA, CA 19-9 and TPA in the diagnosis of pancreatic cancer. Evaluation by discriminant analysis].
Minerva Med. 1986 Apr 14;77(16):613-6.
8
A prospective study of serum tumour markers carcinoembryonic antigen, carbohydrate antigens 50 and 242, tissue polypeptide antigen and tissue polypeptide specific antigen in the diagnosis of pancreatic cancer with special reference to multivariate diagnostic score.
Br J Cancer. 1994 Mar;69(3):562-5. doi: 10.1038/bjc.1994.102.
9
The role of the leukocyte adherence inhibition (LAI), CA 19-9, and tissue polypeptide antigen (TPA) tests in the diagnosis of pancreatic cancer.
Cancer. 1989 Sep 1;64(5):1103-6. doi: 10.1002/1097-0142(19890901)64:5<1103::aid-cncr2820640522>3.0.co;2-c.
10
Differential diagnosis of pancreatic cancer and chronic pancreatitis by a monoclonal antibody detecting a new cancer-associated antigen (CA 19-9).
Ric Clin Lab. 1984 Jul-Sep;14(3):303-6. doi: 10.1007/BF02904849.
引用本文的文献
1
Serum tumor markers in pancreatic cancer-recent discoveries.
Cancers (Basel). 2010 Jun 2;2(2):1107-24. doi: 10.3390/cancers2021107.
2
Laboratory tests in the diagnosis of the chronic pancreatic diseases. Part 6. Differentiation between chronic pancreatitis and pancreatic cancer.
Int J Pancreatol. 1988 May;3(4):229-40. doi: 10.1007/BF02788452.
3
Serum tissue polypeptide antigen in pancreatic cancer and other gastrointestinal diseases.
J Clin Pathol. 1989 May;42(5):555. doi: 10.1136/jcp.42.5.555-a.
4
Tumour associated antigens in diagnosis of serous effusions.
J Clin Pathol. 1988 Jun;41(6):633-43. doi: 10.1136/jcp.41.6.633.
5
Diagnostic value of serum tumor markers in skeletal metastasis of carcinomas.
Arch Orthop Trauma Surg. 1990;109(5):247-51. doi: 10.1007/BF00419937.
本文引用的文献
1
"Plasma"-type ribonuclease in pancreatic cancer diagnosis: a critical appraisal.
Hepatogastroenterology. 1981 Dec;28(6):316-8.
2
Serum ferritin in pancreatic disease. An accurate test of malignancy?
Digestion. 1982;25(4):258-62. doi: 10.1159/000198842.
3
Evaluation of a new tumor-associated antigen in pancreatic cancer.
Digestion. 1984;29(1):1-4. doi: 10.1159/000199000.
4
Serum tissue polypeptide antigen in chronic pancreatic disease. Does hepatic damage have any influence?
Ric Clin Lab. 1984 Jul-Sep;14(3):425-9. doi: 10.1007/BF02904866.
5
New oncofetal antigen for human pancreas.
Lancet. 1974 Apr;1(7859):643-5. doi: 10.1016/s0140-6736(74)93197-3.
6
CA 19-9 in the differential diagnosis between pancreatic cancer and chronic pancreatitis.
Eur J Cancer Clin Oncol. 1985 Apr;21(4):429-32. doi: 10.1016/0277-5379(85)90032-x.
7
Elevated serum ribonuclease in patients with pancreatic cancer.
Proc Natl Acad Sci U S A. 1976 Jul;73(7):2308-10. doi: 10.1073/pnas.73.7.2308.
8
Circulating carcinoembryonic antigen in pancreatic carcinoma.
Cancer. 1978 Sep;42(3 Suppl):1468-71. doi: 10.1002/1097-0142(197809)42:3+<1468::aid-cncr2820420816>3.0.co;2-i.
9
A preliminary evaluation of tissue polypeptide antigen in serum or urine (or both) of patients with cancer or benign neoplasms.
Clin Chem. 1978 Jun;24(6):868-72.
10
Tissue polypeptide antigen (TPA): Biology, biochemistry, improved assay methodology, clinical significance in cancer and other conditions, and future outlook.
Antibiot Chemother (1971). 1978;22:16-31.
Zotero 插件